Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-06-15 | 2022-06-15 |
| Drug Identification Number | 02243588 | 02243588 |
| Brand name | MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN-NITRO SUBLINGUAL SPRAY |
| Common or Proper name | NITROGLYCERIN SUBLINGUAL SPRAY | NITROGLYCERIN SUBLINGUAL SPRAY |
| Company Name | MYLAN PHARMACEUTICALS ULC | MYLAN PHARMACEUTICALS ULC |
| Ingredients | NITROGLYCERIN | NITROGLYCERIN |
| Strength(s) | 0.4MG | 0.4MG |
| Dosage form(s) | METERED-DOSE AEROSOL | METERED-DOSE AEROSOL |
| Route of administration | SUBLINGUAL SUBLINGUAL | SUBLINGUAL SUBLINGUAL |
| Packaging size | 1BT | 1BT |
| ATC code | C01DA | C01DA |
| ATC description | VASODILATORS USED IN CARDIAC DISEASES | VASODILATORS USED IN CARDIAC DISEASES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2022-05-24 | 2022-05-24 |
| Estimated end date | ||
| Actual end date | 2022-06-14 | 2022-06-14 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Quality Hold | Quality Hold |
| Health Canada comments |